DZ Bank
ONCE

DZ Bank’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

DZ Bank’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3,900
Closed -$260K – 1173
2018
Q1 		$260K Buy
+3,900
New +$225K ﹤0.01% 890

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

DZ Bank's ONCE Position: Q2 2018 in Review

DZ Bank sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2018, closing a stake of 3,900 shares — an estimated $260K sold.

DZ Bank first reported a position in ONCE in Q1 2018 and held it in 1 quarter. The position peaked at $260K in Q1 2018. 172 funds tracked by Wall St. Rank hold ONCE as of Q2 2018.

  • DZ Bank reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • DZ Bank sold 3,900 Spark Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $260K.
  • DZ Bank first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • DZ Bank's Spark Therapeutics, Inc. Common Stock position peaked at $260K in Q1 2018.
  • 172 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.